A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2004
12/08/2004	EP1482982A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof
12/08/2004	EP1482981A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
12/08/2004	EP1482977A1 Combination therapies for treating methylthioadenosine phosphorylase deficient cells
12/08/2004	EP1482974A2 Electroporation methods for introducing bioactive agents into cells
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482970A1 Cancer therapy
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
12/08/2004	EP1482944A2 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482943A2 Dosing regimen for gemcitabine hcv therapy
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482933A2 Potent, simplified derivatives of immunosuppressive agents
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482920A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
12/08/2004	EP1482911A1 Dispersed solid-containing complex carbohydrate
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482796A1 Stable compositions comprising tezacitabine
12/08/2004	EP1482795A1 New immunoeffector compounds
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1252155B1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
12/08/2004	EP1233787B1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1172386B1 Functionalized glycosaminoglycan polymer and medical instruments and drugs by using the same
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP1117418B1 Plant extracts for the treatment of increased bone resorption
12/08/2004	EP1027330B1 Styryl sulfone anticancer agents
12/08/2004	EP1015015A4 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	EP0981342B1 Method and composition for treating cancers
12/08/2004	EP0975329B1 Lipid complexes of highly insoluble platinum complexes
12/08/2004	EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
12/08/2004	CN1554026A Prognostic indicator
12/08/2004	CN1553958A Photochemical internalization for delivery of molecules into the cytosol
12/08/2004	CN1553918A Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
12/08/2004	CN1553906A VARIOLIN derivatives and their use as antitumor agents
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553900A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
12/08/2004	CN1553899A Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/08/2004	CN1553897A Dolastatin 10 derivatives
12/08/2004	CN1553895A Taxol enhancer compounds
12/08/2004	CN1553894A Taxol enhancer compounds
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553815A Pharmaceutical formulation for the intramuscular administration of fulvestrant
12/08/2004	CN1553807A Compositions comprising mixtures of therapeutic proteins and methods of producing the same
12/08/2004	CN1553803A Use of 4-pyridylmethylphthalazines for cancer treatment
12/08/2004	CN1553802A 喜树碱衍生物 Camptothecin derivatives
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1552888A Production of polysaccharide protein by deep fermemtation of hysteriales for anticancer
12/08/2004	CN1552880A Use and constructing plan of anticancer recombined gland virus with tumour CHK1 as target of medicine
12/08/2004	CN1552879A Use and obtain of inactivating lumour CHK1 gene anticancer recombined gland virus constituent
12/08/2004	CN1552878A Use and obtain of selective inactivating tumour PLK1 anticancer recombined gland virus constituent
12/08/2004	CN1552877A Use and constructing method for anticancer recombined gland virus with tumour cell PLK1 as target of medicine
12/08/2004	CN1552876A Targetted liver cancer AFP gene siRNAs expression carrier and its constructing method and use
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552736A Monoclone antibody against HnRNP A2/B1 antigen, its preparation and use
12/08/2004	CN1552735A Engineering antibody against CD44 for inducing leukemia cell differentation and necrosis
12/08/2004	CN1552734A Recombination glant associated virus carrier induced TNF concerned cytonecrosis ligand peptide segment and its use
12/08/2004	CN1552727A Targetted polypeptide for specificity of liver cancer blood vessel
12/08/2004	CN1552725A Preparation of solanine sulfurate and its use in medicine
12/08/2004	CN1552724A Preparation of solanine and its use in medicine
12/08/2004	CN1552712A New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
12/08/2004	CN1552711A Yageine derivative compounds and their uses
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552435A Medicine for preventing tumour
12/08/2004	CN1552434A Chinese patent drug for treating liver cancer
12/08/2004	CN1552427A Plaster for treating tumour and tuberculosis etc. diseases
12/08/2004	CN1552328A Use of phenoxthine compounds in preparing medicnies for inhibiting cancers and promoting radio-sensitive medicines
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178938C 1,2-annelated quinoline derivatives
12/08/2004	CN1178907C 3-(fatty acid)-1,2 gluceride disulfate and its preparing method and application
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178900C Anti-tumour agents
12/08/2004	CN1178678C Process for preparing arnebia root medicine with broad-spectrum medical functions
12/08/2004	CN1178663C Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
12/08/2004	CN1178658C Process for synthesizing Cox-2 inhibitors
12/08/2004	CN1178655C Water-miscible pharmaceutical compositions of paclitaxel
12/08/2004	CN1178651C Lyophilized thioxanthenone anti-tumor agents
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828338 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828320 Heterocyclic compounds
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828312 Therapy of mammal susceptible to, suffering from, suspected of having or recovering from a disease impacted by tissue factor(TF), by administering TF blocking compound
12/07/2004	US6828150 Antigen presenting system and methods for activation of T-cells
12/07/2004	US6827940 Forming nontoxic, stable, water soluble antitumor powders; heat and acid treatment of gram positive bacteria containing peptidoglycan, removing insolubles, neutralizing and lyophil-izing
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect

1 ... 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 ... 2211